02.02.2016 14:30
Aleva Neurotherapeutics, a leading company developing next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s disease and essential tremor, announced a strategic development, supply, and manufacturing relationship with Greatbatch. In addition, Greatbatch will invest in Aleva Neurotherapeutics’ current Series C financing round.